4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

A new guideline for the management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death has been published by the European Society of …

Cardiomyopathies represent significant contributors to cardiovascular morbidity and
mortality. Over the past decades, a progress has occurred in characterization of the genetic …

Background Previous studies of radiofrequency catheter ablation (RFA) of ventricular
tachycardia (VT) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) …

Abstract This Canadian Cardiovascular Society position statement is focused on the
management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that …

Arrhythmogenic cardiomyopathy (ACM) is an inherited disorder characterized by structural
and electrical cardiac abnormalities, including myocardial fibro-fatty replacement. Its …

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also called arrhythmogenic right
ventricular dysplasia or arrhythmogenic cardiomyopathy, is a genetic disease characterised …

Arrhythmogenic cardiomyopathy (ACM) is a disease characterized by a progressive
replacement of myocardium by fibro-adipose material, predisposing to ventricular …

Background The pathologic process of ARVC (arrhythmogenic right ventricular
cardiomyopathy) typically originates in the epicardium or subepicardial layers with …

Endocardial-epicardial (Endo-epi) catheter ablation (CA) has been shown to reduce the rate
of ventricular arrhythmia (VA) ablation in patients with structural heart disease (SHD) …